icotec

Executive Summary

icotec ag is a Swiss medical device company pioneering the use of carbon-fiber-reinforced polymer (CFRP) implants for spinal oncology. Its flagship product, BlackArmor®, is a radiolucent composite that allows for improved post-operative imaging and radiation therapy planning compared to traditional metal implants. The company addresses a critical unmet need: patients with spinal tumors often require adjuvant radiotherapy, and metal artifacts can compromise treatment accuracy. icotec’s technology enhances visualization and dose delivery, potentially improving clinical outcomes and quality of life. Founded in 1999 and headquartered in Altstätten, Switzerland, icotec has established a strong foothold in Europe and is now poised for global expansion, particularly in the US and Asia-Pacific markets, where the incidence of spinal metastases is rising.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for expanded spinal tumor indications70% success
• Q2 2026Publication of long-term clinical outcomes from European registry study80% success
• H2 2026Strategic distribution partnership in Asia-Pacific60% success